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Objective: Physical restraints are associated with severe side effects and suffering. A comprehensive,
person-centered, methodology was implemented in 41 Spanish nursing homes to safely eliminate
restraints.
Methods: Data were collected in 2 waves: September 2011 (at the beginning of the intervention,
n ¼ 4361) and September 2014 (n ¼ 5051). Use of 10 different types of physical restraints was recorded,
as well as frequency of psychotropic medication prescription, falls, and mortality.
Results:Mean age was 83.4 (SD 8.5) and 63.5% of the residents had dementia. Frequency (95% conﬁdence
interval) of people having at least 1 restraint was reduced from 18.1% (17.0e19.3) to 1.6% (1.3e2.0). Use of
benzodiazepines was also reduced, with no signiﬁcant changes in other psychotropic medications and
mortality. The rate of total falls increased from 13.1% (12.1e14.1) to 16.1% (15.1e17.1), with no signiﬁcant
increase in injurious falls.
Conclusion: Physical restraints can almost completely be eliminated with reasonable levels of safety.
 2016 AMDA e The Society for Post-Acute and Long-Term Care Medicine. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Regular use of physical restraints in care homes has been regarded
implicitly or explicitly as an indicator of poor quality of care.1 People
with dementia are particularly affected by these organizational be-
haviors,2,3 which convey severe psychological and physical side ef-
fects4 along with diminution of human rights.5 Hence, many
developed and developing countries face the challenge of minimizing,
if not avoiding restraints entirely.
In many countries, physical restraints are all too often used for
organizational convenience, ignorance of their consequences and
possible alternatives, or due to understaffed homes. Prevalence of use
varies considerablyamongcountries. In 1997, Spainwas reported tohave
a staggering 39.6% of residents physically restrained at least once daily.6aria from Sanitas Residencial
vention. Sergio Gómez, David
ás are employed by Sanitas
hD, Maria Wolff Foundation,
.
and Long-Term Care Medicine. ThSimilar levels (38%) were reported earlier from the United States7 or
Hong Kong.8 More recently, prevalences of restraint of 21.5% and 41.2%
were reported, respectively, for elderly residents and for residents with
dementia in theSpanish regionofCatalonia.9 Fortunately, severalplayers
like nongovernmental organizations, private companies, and local gov-
ernments (2011 Use of Restraint Act of the Navarra Government) are
promoting initiatives to reduceor eliminate physical restraints. Not all of
these initiatives show the same degree of success.
During the rationalization process that eventually takes place in
these countries, pros and cons of restraints are hotly debated, as they
affect injurious falls, legal issues, environmental management, staff-
ing, attitudes, costs, psychotropic drug prescription, safety-dignity-
liberty trilemma, and so forth.10 To help the debate factually, we
publish the results of a longitudinal, multicomponent, multilevel
psychosocial and training program aimed at delivering person-
centered care for people with dementia with the objective (among
others) of reducing physical restraints. This program, which was
conducted throughout 41 nursing homes distributed over most
Spanish regions, takes approximately 3 years per home to
implement.is is an open access article under the CC BY-NC-ND license (http://creativecommons.
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Setting and General Procedure
This was a 2-wave longitudinal study conducted by a partnership
of Maria Wolff Foundation and Sanitas Residencial (SR), the Spanish
branch of the British United Provident Association (BUPA), which is
composed of 41 nursing homes. A corporate project to provide
restraint-free, person-centered care was designed and implemented
in a modular fashion. Data from the early (September 2011) and pre-
ﬁnal (September 2014) stages of the project are described and
analyzed in the present paper. Data from the period of September 1
to September 30, 2011, were collected on October 1, 2011, and data
from the period of September 1 to September 30, 2014, were
collected on October 1, 2014. Medical status data were recorded in
the corporate nursing home software/database (ResiPlus v3.0.11;
ADD Informática, Valencia, Spain) by SR medical doctors and nurses
in charge of the residents (in Spain, each nursing home employs at
least 1 medical doctor to handle residents’ medical treatments).
Each nursing home dataset was later extracted and consolidated
into 1 single database by 2 information technology (IT) engineers
(SG, RH) at SR headquarters. Data were reviewed for potential ar-
tifacts and errors by the IT engineer, the chain’s head of clinical
management (DC), the principal investigator (RM), and the study
director (JO). Data were exported from MS Access to MS Excel
(Microsoft, Redmond, WA) and from there into SPSS v.10.0 (SPSS
Inc., Chicago, IL). General consent for the research use of clinical
data was obtained on admission from residents or, if not capable, by
closest relative or legal representative. In addition, speciﬁc approval
for the present investigation was obtained from an institutional
ethics committee.Description of the Intervention
The intervention was initiated April 2010 and combines training,
consultation, and consultancy at various levels of the organization.
“Dementia champions” (1 per nursing home) received in-depth
training about a wide array of dementia topics (eg, biological basis
of dementia, genesis and management of behavioral and psychologi-
cal symptoms of dementia [BPSD], person-centered care) needed to
coordinate implementation of several dementia care components in
each home. Most homes added a speciﬁc restraint reduction coordi-
nator who received extra training and support. Home managers
received summarized ad hoc training of these topics. Medical doctors
were trained to rationalize and optimize the prescription of psycho-
tropics at all levels of the organization. A longitudinal home-by-home
training program was designed to implement a dementia-friendly
culture as well as speciﬁc organizational skills relevant to person-
centered care and environmental improvement. Approximately 70%
of staff of each home attended the training sessions. Employees
trained in the homes included medical staff, nurses, nurse aides,
therapists, laundry and kitchen, maintenance, reception, administra-
tion, and senior and middle management personnel.
The training sequence was divided into 1-day modules, as follows:
- Module 1. Basic knowledge of dementia with emphasis on
Alzheimer disease.
- Module 2. Perception, nutrition, and feeding issues related to
dementia.
- Module 3. Understanding, preventing, and treating BPSD.
- Modules 4e6. Restraint avoidance and elimination, basics for
fall prevention, legal issues, and ethics and caregivers.
- Module 7. Fall prevention without restraints.
Each trainingmodule had speciﬁc procedural components that had
to be implemented after training. Implementation was controlled bycentralized quality control management systems, videoconference
with the trainers, and annual conferences and presentations. Each
module lasted approximately 4 hours, usually delivered in a single
day. Depending on nursing home size, modules were delivered to 1 or
more groups of up to 25 staff members. From module 1 to module 7, a
time span of 2 or 3 years could elapse.
Special attention was given to internal quality control parameters
to monitor implementation. These parameters were, among others
(1) use of the Functional Assessment Staging tool11; (2) use of
dysphagia assessment tools and organization of feeding; (3) use of
no-rinse soap; (4) documentation of falls history, root cause analysis
of key falls, and individualized fall prevention programs; (5) quality
prescription of psychotropic medication; and (6) use of restraints
(Figure 1).
To ensure objectivity, 2 external organizations audited the nursing
homes after restraints were removed.
Study Variables
The following types of restraints were considered for the present
investigation: upper body vest restraint, chair abdominal belt, bed
abdominal belt, upper body vest and perineal belt, hand mitts, wrist
restraints, restraint sheet, table tray, t-type abdominal restraint, and
other restraints. Bed rails and bed-rail protectors were not considered
restraints.12
Psychotropic medications were divided into the following cate-
gories: typical neuroleptics; risperidone; quetiapine; other atypical
neuroleptics; antidepressants; short half-life benzodiazepines (BZDs);
middle half-life BZDs; long half-life BZDs; BZDs (of any type) admin-
istered only if needed; other hypnotic, sedative, or anxiolytic drugs;
cholinesterase inhibitors (CEIs); and memantine.
Falls were coded only if they happened and, when present, inju-
rious falls were deﬁned as including at least 1 of the following con-
sequences: hip fracture, other fracture, head injury (from light injuries
with hematoma to severe head trauma), or other type of injury (skin
erosion, bruise, bleeding wound, hematoma, or edema). In absence of
any of those items, falls were accounted for as noninjurious. Cognitive
status was documented using the last available “Miniexamen
Cognoscitivo” (MEC),13 which was conducted once a year for every
resident (the MEC is a Spanish adaptation of the Mini-Mental State
Examination).14 A cutoff of 23/24was used to determine if the resident
had dementia or not.
Statistical Analyses
The study variables were described and compared for the
following predeﬁned samples of interest: (1) total sample at ﬁrst
wave, (2) total sample at second wave, (3) new patients at second
wave, and (4) patients evaluated at both study waves. Descriptive
statistics were used and, for the sample of patients who were evalu-
ated at both study waves, intraindividual evolution was analyzed us-
ing Wilcoxon test. All the descriptions and analyses were
systematically conducted for the total sample and for the subsample of
people who had dementia. Finally, Spearman correlation coefﬁcients
were calculated to investigate the possible associations and mecha-
nisms of restraint use, which may help to understand restraint causes
and to reduce them in the future. The Spearman r coefﬁcient was
interpreted as follows: negligible, <0.20; weak, 0.20e0.34; moderate,
0.35e0.50; strong, >0.50.15
Results
Data were collected from a total of 7657 individuals (4361
total sample at ﬁrst wave, 5051 total sample at second wave, 3296
new patients at second wave, and 1755 patients evaluated at both
Fig. 1. Essential components of the Maria Wolff restraint-free care program for nursing homes. BPSD, behavioral and psychological symptoms of dementia; FAST, Functional
Assessment Staging; NPT, non-pharmacological therapies; QC, quality control.
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different study samples are presented in Table 1. There were 46
deaths (1.1%) and 165 residents (3.8%) abandoned the nursingTable 1
Demographic and Clinical Characteristics of the Residents
September 2011 September 2014
Total Sample, n ¼ 4361 Total Sample, n ¼ 5051 New Residents
Age 84.6 (8.6) 85.3 (8.5) 84.9 (8.1)
Sex, % female 73.6 73.9 71.8
Weight, kgy 62.0 (14.2) 61.9 (14.1) 62.0 (13.7)
Height, cmz 154.7 (9.8) 155.8 (9.6) 156.3 (9.8)
BMIx 25.9 (5.5) 25.4 (5.4) 25.3 (5.2)
Medications, n 8.2 (4.1) 7.3 (3.8) 7.5 (3.8)
FASTjj 4.6 (2.0) 4.5 (2.0) 4.4 (2.0)
MEC{ 17.4 (11.6) 16.9 18.0 (11.0)
Dementia, %{ 61.8 64.9 62.5
BMI, body mass index; FAST, Functional Assessment Staging; NS, statistically not signiﬁc
Figures represent mean value (SD), unless % is indicated.
*Wilcoxon test.
yn ¼ 4095, 4754, 3023, 1679 due to missing values.
zn ¼ 3460, 4441, 2700, 1427 due to missing values.
xn ¼ 3419, 4373, 2655, 1401 due to missing values.
jjn ¼ 3487, 4623, 2886, 1471 due to missing values.
{n ¼ 3902, 4623, 2855, 1636 due to missing values.home during the ﬁrst study wave; the corresponding ﬁgures
for the second study wave were, respectively, 72 (1.4%) and 209
(4.1%).Residents Who Were Evaluated at Both Study Waves
, n ¼ 3296 September 2011, n ¼ 1755 September 2014, n ¼ 1755 P*
83.1 (9.2) 86.1 (9.2) <.0005
77.9 77.9 NS
64.1 (14.2) 61.7 (14.8) <.0005
154.5 (9.5) 155.3 (9.4) <.0005
26.8 (5.5) 25.7 (5.7) <.0005
7.9 (4.0) 7.0 (3.9) <.0005
4.3 (2.0) 4.8 (2.0) <.0005
18.6 (11.5) 15.1 (12.0) <.0005
57.2 69.0 <.0005
ant.
Table 2
Physical Restraint Prescription in the Study Samples
September 2011 September 2014 Residents Who Were Evaluated at Both Study Waves
All Residents,
(n ¼ 4361),
(n ¼ 2410)
All Residents,
(n ¼ 5051),
(n ¼ 2961)
New Residents,
(n ¼ 3296),
(n ¼ 1783)
September 2011,
(n ¼ 1755),
(n ¼ 937)
September 2014,
(n ¼ 1755),
(n ¼ 937)
P*
Restraints, n (SD) (range) 0.24 (0.55) (0e4) 0.02 (0.18) (0e4) 0.02 (0.17) (0e4) 0.21 (0.52) (0e3) 0.03 (0.20) (0e2) <.0005
0.39 (0.67) (0e4) 0.03 (0.22) (0e4) 0.03 (0.22) (0e4) 0.35 (0.65) (0e3) 0.04 (0.23) (0e2) <.0005
At least 1 restraint 18.1 (17.0e19.3) 1.6 (1.3e2.0) 1.2 (0.8e1.6) 15.6 (13.9e17.3) 2.5 (1.8e3.2) <.0005
29.1 (27.3e30.9) 2.2 (1.7e2.8) 1.8 (1.2e2.4) 26.0 (23.2e28.9) 3.0 (1.9e4.1) <.0005
Upper body vest restraint 1.2 (0.9e1.6) 0.0 (0.0e0.0) 0 (NA) 1.2 (0.7e1.7) 0 (NA) <.0005
2.1 (1.6e2.8) 0 (NA) 0 (NA) 2.1 (1.2e3.1) 0 (NA) <.0005
Chair abdominal belt 9.4 (8.6e10.3) 0.9 (0.6e1.2) 0.8 (0.5e1.1) 7.9 (6.7e9.2) 1.2 (0.7e1.7) <.0005
15.1 (13.6e16.5) 1.4 (1.0e1.8) 1.2 (0.7e1.7) 13.1 (11.0e15.3) 2.0 (1.1e2.9) <.0005
Upper body vest and perineal belt 3.4 (2.9e4.0) 0.1 (0.0e0.2) 0.0 (0.0 to 0.1) 2.6 (1.8e3.3) 0.2 (0.0e0.5) <.0005
5.7 (4.8e6.7) 0.1 (0.0 to 0.2) 0.1 (0.1 to 0.2) 4.3 (3.0e5.6) 0.1 (0.1 to 0.3) <.0005
Mitts 0.8 (0.5e1.1) 0.1 (0.0e0.2) 0.1 (0.0 to 0.1) 0.6 (0.3e1.0) 0.2 (0.0e0.5) .052
1.1 (0.7e1.5) 0.2 (0.0e0.3) 0.1 (0.1 to 0.2) 1.0 (0.3e1.6) 0.3 (0.0 to 0.7) .083
Wrist restraint 0.8 (0.5e1.1) 0.1 (0.0 to 0.1) 0.1 (0.0 to 0.2) 0.5 (0.2e0.8) 0 (NA) .003
1.4 (0.9e1.8) 0.1 (0.0 to 0.2) 0.2 (0.0 to 0.4) 1.0 (0.3e1.6) 0 (NA) <.0005
Lap tray 0.1 (0.0e0.2) 0.0 (0.0e0.0) 0 (NA) 0.1 (e0.1 to 0.2) 0 (NA) .317
0.2 (0.0e0.3) 0 (NA) 0 (NA) 0.1 (e0.1 to 0.3) 0 (NA) .318
T-abdominal belt 1.4 (1.0e1.7) 0.3 (0.2e0.5) 0.1 (0.0e0.2) 1.1 (0.6e1.6) 0.7 (0.3e1.1) .157
2.2 (1.6e2.7) 0.2 (0.0e0.4) 0.1 (0.0 to 0.3) 1.7 (0.9e2.5) 0.3 (0.0 to 0.7) .003
Bed abdominal belt 5.9 (5.2e6.6) 0.6 (0.3e0.8) 0.5 (0.2e0.7) 6.0 (4.9e7.2) 0.7 (0.3e1.1) <.0005
9.8 (8.6e11.0) 0.9 (0.6e1.3) 0.8 (0.4e1.3) 10.6 (8.6e12.5) 1.0 (0.3e1.6) <.0005
Restraint sheet 0.6 (0.4e0.8) 0.0 (0.0e0.0) 0 (NA) 0.5 (0.2e0.8) 0 (NA) .003
1.0 (0.6e1.4) 0 (NA) 0 (NA) 1.0 (0.3e1.6) 0 (NA) <.0005
Other restraint 0.3 (0.1e0.5) 0.5 (0.3e0.7) 0.4 (0.2e0.6) 0.2 (0.0e0.5) 0.6 (0.3e1.0) .020
0.5 (0.2e0.7) 0.7 (0.4e1.0) 0.6 (0.2e0.9) 0.3 (0.0 to 0.7) 0.9 (0.3e1.4) .025
Bed railsy 43.5 (42.0e44.9) 41.7 (40.4e43.1) 37.7 (36.1e39.4) 38.9 (36.6e41.1) 49.2 (46.9e51.6) <.0005
56.8 (54.8e58.7) 52.7 (50.9e54.5) 49.0 (46.6e51.3) 52.7 (49.5e55.9) 61.7 (58.6e64.8) <.0005
Bed-rail protectorsy 0.6 (0.4e0.9) 0.3 (0.1e0.4) 0.2 (0.1e0.4) 0.2 (0.0e0.5) 0.3 (0.0e0.5) .706
1.0 (0.6e1.3) 0.3 (0.1e0.5) 0.3 (0.1e0.6) 0.4 (0.0e0.8) 0.4 (0.0e0.8) 1.000
NA, not applicable.
Figures represent frequency (%) of prescription (95% CI), unless otherwise indicated (all residents up, residents with dementia down).
*Wilcoxon test.
yBed rails and bed-rail protectors were not considered restraints.
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1.6% after the implementation of a great part of the restraint reduction
program (the restraints reduction program still continues at the
moment this article is written) and the reduction of restraints was
even greater in the residents with dementia (from 29.1% to 2.2%,
Table 2). Signiﬁcant restraint reduction was achieved for virtually all
the types of restraints (only the category of “other types of restraints”
remained unchanged). The subanalysis of those residents admitted
after the ﬁrst wave (during the cultural change) reported even less use
of restraints (1.2%). Moreover, highly restrictive restraints like
T-abdominal belts (includes groin restraint) virtually disappeared in
the new residents (0.1%).
A reduction of physical restraints was also observed when the
residents who were evaluated at both study waves were analyzed
separately (15.6% to 2.5% in all the residents, 26.0% to 3.0% in the
residents with dementia), againwith signiﬁcant reduction achieved in
virtually all types of restraints. Minimal increase of prescription was
observed in the category of “other restraint” (0.2%e0.6%, 0.3%e0.9% in
the residents with dementia) (Table 2).
There was no signiﬁcant difference in use of bed rails at both
study waves when the total samples were compared (43.5% vs 41.7%);
however, an increase in use of bed rails was observed in the sub-
sample of residents present at both waves (38.9%e49.2%, Table 2).
Post hoc descriptions of the evolution of bed restraint (either
abdominal belt or restraint sheet) and bed rails were conducted to
further illustrate how the different combinations of the ﬁrst wave
evolved into at the second wave. It was detected that 344 (79.1%) of
435 residents having bed restraint but not bed rails at ﬁrst wave were
switched to bed rails at the second wave. In addition, 306 (29.3%) of
1046 residents having neither bed rails nor bed restraint at the ﬁrstwave ended up having bed rails in the second wave. Residents having
both bed restraint and bed rails were untied by 91.7% (221/241),
although bed rails remained with 79.7% of those people (192/241). In
contrast, new residents at the second wave used fewer side rails than
residents at the ﬁrst wave (37.7% [36.1e39.4] vs 43.5% [42.0e44.9],
Table 2).
Globally considered, the frequency of neuroleptic prescription did
not change across both study waves; however, there was a 2.7%
decrease in the prescription of typical neuroleptics, along with 5% in-
crease in the prescription of quetiapine and 2% decrease in the pre-
scription of risperidone. There was also a 10.2% decrease in BZD
prescription, accompanied by 2.7% increase in antidepressant pre-
scription. Prescriptionof BZDswasparticularly lowered in the residents
who were evaluated in both study waves (43.8% to 30.6%). Also in that
sample, small decreases were observed in the use of risperidone (7.8%
to 5.5%); typical neuroleptics (7.1% to 4.6%); antidepressants (42.3% to
39.0%); and other hypnotic, sedative, or anxiolytic drugs (7.1% to 5.2%).
This global decrease in psychotropic medication prescriptionwas even
greater in the residents who had dementia (Table 3).
There was an increase in the proportion of residents who expe-
rienced at least 1 fall in the second wave, which reached statistical
signiﬁcance for the new residents (ie, those residents who were
admitted to the nursing home once the restraint reduction inter-
vention had been initiated [12.9% vs 10.3%]). Although the proportion
of residents who experienced noninjurious falls remained unchanged
(6.8%), a trend of increase in injurious falls was observed at the
second wave (5.1% vs 4.3%), with most injurious falls ﬁlling the
category of “other type of complication” (Table 4). In contrast, a
reduction in the proportion of fallers was observed in the residents
who were evaluated twice (ie, those residents who had been
Table 3
Psychotropic Medication Prescription in the Study Samples
September 2011 September 2014 Residents Who Were Evaluated at Both Study Waves
All Residents,
(n ¼ 4361),
(n ¼ 2410)
All Residents,
(n ¼ 5051),
(n ¼ 2961)
New Residents,
(n ¼ 3296),
(n ¼ 1783)
September 2011,
(n ¼ 1755),
(n ¼ 937)
September 2014,
(n ¼ 1755),
(n ¼ 937)
P*
Typical neuroleptics 7.0 (6.3e7.8) 4.3 (3.7e4.9) 4.2 (3.5e4.8) 7.1 (5.9e8.3) 4.6 (3.6e5.5) <.0005
9.1 (7.9e10.2) 4.9 (4.1e5.6) 4.8 (3.8e5.8) 9.2 (7.3e11.0) 5.2 (3.8e6.7) <.0005
Quetiapine 11.0 (10.0e11.9) 16.0 (15.0e17.0) 17.5 (16.2e18.8) 11.2 (9.7e12.6) 13.3 (11.7e14.9) .005
13.9 (12.5e15.2) 20.2 (18.7e21.6) 23.2 (21.3e25.2) 14.9 (12.7e17.2) 15.7 (13.4e18.0) .503
Risperidone 8.2 (7.4e9.0) 6.3 (5.6e6.9) 6.6 (5.7e7.4) 7.8 (6.6e9.1) 5.5 (4.5e6.6) <.0005
10.1 (8.9e11.3) 7.1 (6.1e8.0) 8.2 (6.9e9.5) 9.9 (8.0e11.8) 5.8 (4.3e7.3) <.0005
Other atypical neuroleptics 3.9 (3.3e4.1) 3.3 (2.8e3.8) 2.6 (2.0e3.1) 4.7 (3.7e5.7) 4.7 (3.7e5.7) 1.000
3.9 (3.1e4.6) 2.7 (2.1e3.3) 1.9 (1.3e2.5) 5.3 (3.9e6.8) 4.4 (3.1e5.7) .083
Antidepressants 39.7 (38.3e41.2) 42.4 (41.1e43.8) 44.3 (42.6e46.0) 42.3 (40.0e44.6) 39.0 (36.7e41.3) .003
38.6 (36.6e40.5) 42.7 (40.9e44.5) 46.7 (44.3e49.0) 41.8 (38.7e45.0) 34.7 (31.6e37.7) <.0005
BZD, short half-life 0.4 (0.2e0.6) 0.4 (0.2e0.6) 0.5 (0.3e0.8) 0.3 (0.0e0.5) 0.2 (0.0 to 0.4) .317
0.5 (0.2e0.8) 0.3 (0.1e0.5) 0.4 (0.1e0.8) 0.4 (0.0e0.8) 0.1 (0.1 to 0.3) .083
BZD, middle half-life 37.4 (36.0e38.9) 29.1 (27.7e30.2) 30.5 (28.9e32.1) 37.0 (34.7e39.2) 25.0 (23.9e28.0) <.0005
33.8 (31.9e35.7) 23.6 (22.0e25.1) 25.5 (23.5e27.5) 32.0 (29.0e35.0) 18.5 (16.0e20.9) <.0005
BZD, long half-life 7.8 (7.0e8.6) 5.7 (5.0e6.3) 5.6 (4.8e6.4) 9.2 (7.8e10.5) 5.8 (4.7e6.9) <.0005
7.1 (6.1e8.1) 4.3 (3.6e5.0) 3.9 (3.0e4.8) 7.8 (6.1e9.5) 4.5 (3.2e5.8) <.0005
BZD, if needed 4.6 (4.0e5.2) 2.1 (1.7e2.5) 2.4 (1.9e2.9) 4.2 (3.2e5.1) 1.6 (1.0e2.2) <.0005
4.5 (3.7e5.4) 1.7 (1.2e2.2) 2.0 (1.3e2.6) 4.3 (3.0e5.6) 1.2 (0.5e1.9) <.0005
BZD, any type of prescription 43.6 (42.1e45.1) 33.5 (32.2e34.8) 35.0 (33.4e36.6) 43.8 (41.5e46.1) 30.6 (28.4e32.8) <.0005
39.5 (37.6e41.5) 27.3 (25.7e28.9) 29.1 (26.9e31.2) 38.3 (35.2e41.4) 22.4 (19.7e25.1) <.0005
Other hypnotics, sedatives, or anxiolytics 7.4 (6.7e8.2) 6.2 (5.5e6.9) 6.7 (5.9e7.6) 7.1 (5.9e8.3) 5.2 (4.2e6.3) .009
8.2 (7.1e9.3) 5.9 (5.0e6.7) 6.5 (5.4e7.7) 8.9 (7.0e10.7) 4.5 (3.2e5.8) <.0005
CEI 13.6 (12.6e14.6) 13.8 (12.8e14.7) 15.3 (14.0e16.5) 15.6 (13.9e17.3) 10.8 (9.4e12.3) <.0005
18.5 (16.9e20.0) 17.6 (16.2e18.9) 20.4 (18.5e22.3) 22.1 (19.4e24.7) 13.1 (11.0e15.3) <.0005
Memantine 7.0 (6.2e7.7) 7.7 (6.9e8.4) 8.1 (7.1e9.0) 8.0 (6.7e9.2) 7.0 (5.8e8.1) .063
10.5 (9.3e11.8) 11.1 (10.0e12.2) 12.3 (10.8e13.8) 12.5 (10.4e14.6) 9.1 (7.2e10.9) <.000
Figures represent frequency (%) of prescription (95% CI) (all residents up, residents with dementia down).
*Wilcoxon test.
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was initiated and remained 3 years later, at the second wave [11.3% to
8.6%]). When indexed by population of residents, total number of
falls increased from 0.13 in the ﬁrst wave to 0.16 in the second waveTable 4
Incidence of Falls in the Study Samples
September 2011 September 2014
All Residents,
(n ¼ 4361),
(n ¼ 2410)
All Residents,
(n ¼ 5051),
(n ¼ 2961)
Fall, any type, n (SD) (range) 0.13 (0.45) (0e6) 0.16 (0.56) (0e10)
0.15 (0.49) (0e6) 0.17 (0.58) (0e10)
Fall, any type 10.3 (9.4e11.2) 11.4 (10.5e12.3)
11.2 (9.9e12.4) 12.4 (11.2e13.5)
Noninjurious fall, n (SD) (range) 0.08 (0.34) (0e6) 0.07 (0.32) (0e6)
0.09 (0.38) (0e6) 0.07 (0.32) (0e6)
Noninjurious fall 6.8 (6.0e7.5) 5.8 (5.1e6.4)
7.5 (6.4e8.5) 5.9 (5.1e6.8)
Injurious fall, n (SD) (range) 0.05 (0.25) (0e4) 0.05 (0.24) (0e3)
0.05 (0.26) (0e3) 0.06 (0.26) (0e3)
Injurious fall 4.3 (3.7e4.9) 4.5 (4.0e5.1)
4.6 (3.7e5.4) 5.0 (4.2e5.8)
Fall with hip fracture 0.1 (0.0e0.2) 0.1 (0.0e0.2)
0.1 (0.0 to 0.2) 0.1 (0.0e0.3)
Fall with other type of fracture 0.1 (0.0e0.2) 0.1 (0.0e0.2)
0.1 (0.0 to 0.2) 0.2 (0.0e0.4)
Fall with head injuryy 0.1 (0.0e0.2) 0.2 (0.1e0.3)
0.2 (0.0e0.3) 0.2 (0.0e0.4)
Fall with other type of complicationz 3.4 (2.9e3.9) 4.0 (3.4e4.5)
3.6 (2.9e4.4) 4.3 (3.6e5.1)
NA, not applicable.
Figures represent % of residents (95% CI) who experienced at least 1 fall during the obser
down).
*Wilcoxon test.
yIncludes light head injuries with hematoma to severe head trauma.
zIncludes skin erosion, bruise, bleeding wound, hematoma, or edema.and even 0.19 in the new residents of the second wave. Repeat fallers
(ie, people with more than 1 fall during the 1-month observation
period) increased from 1.9% (95% conﬁdence interval [CI] 1.5e2.3) in
the ﬁrst wave to 2.8% (95% CI 2.3e3.2) in the second wave.Residents Who Were Evaluated at Both Study Waves
New Residents,
(n ¼ 3296),
(n ¼ 1783)
September 2011,
(n ¼ 1755),
(n ¼ 937)
September 2014,
(n ¼ 1755),
(n ¼ 937)
P*
0.19 (0.60) (0e10) 0.11 (0.40) (0e6) 0.11 (0.46) (0e9) .935
0.20 (0.62) (0e10) 0.14 (0.45) (0e6) 0.12 (0.50) (0e9) .311
12.9 (11.8e14.0) 9.2 (7.8e10.5) 8.6 (7.3e9.9) .546
14.2 (12.6e15.9) 11.3 (9.3e13.3) 8.6 (6.8e10.4) .049
0.08 (0.34) (0e4) 0.07 (0.30) (0e6) 0.05 (0.26) (0e6) .012
0.09 (0.34) (0e3) 0.09 (0.36) (0e6) 0.05 (0.30) (0e6) .005
6.8 (6.0e7.7) 6.0 (4.9e7.2) 3.8 (2.9e4.7) .001
7.0 (5.8e8.2) 7.9 (6.2e9.6) 3.9 (2.7e5.2) <.0005
0.06 (0.26) (0e3) 0.04 (0.23) (0e3) 0.04 (0.21) (0e2) .572
0.07 (0.28) (0e3) 0.05 (0.24) (0e3) 0.04 (0.20) (0e2) .222
5.1 (4.3e5.8) 3.7 (2.8e4.6) 3.5 (2.7e4.4) .782
5.7 (4.6e6.8) 4.2 (2.9e5.4) 3.3 (2.2e4.5) .318
0.1 (0.0e0.2) 0.1 (0.0 to 0.3) 0.1 (0.0 to 0.3) 1.000
0.2 (0.0 to 0.4) 0.1 (0.1 to 0.3) 0 (NA) .318
0.2 (0.0e0.3) 0.2 (0.0 to 0.4) 0.1 (0.1 to 0.2) .317
0.3 (0.0e0.5) 0.1 (0.1 to 0.3) 0 (NA) .318
0.2 (0.1e0.4) 0.1 (0.0 to 0.3) 0.1 (0.0 to 0.3) 1.000
0.2 (0.0e0.4) 0.1 (0.1 to 0.3) 0.1 (0.1 to 0.3) 1.000
4.5 (3.8e5.2) 3.0 (2.2e3.8) 3.1 (2.3e3.9) .921
4.9 (3.9e5.9) 3.5 (2.3e4.7) 3.1 (2.0e4.2) .593
vation period, unless otherwise indicated (all residents up, residents with dementia
Fig. 2. Vicious circle of physical restraint, debilitation, and falls in people with
dementia.
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them untied at the second wave) fell signiﬁcantly less in the second
wave (11.3% to 8.6%).
The use of physical restraints was associated with lower bodymass
index (r ¼ 0.23), more functional dependence (r ¼ 0.42), and worse
cognitive performance (r¼0.41) at the ﬁrst wave. Those associations
disappeared in the second-wave correlation analyses (r ¼ 0.09,
r ¼ 0.12, and r ¼ 0.11, respectively).
At the time of the second wave, 26 homes were audited and
reported virtually restraint-free, whereas 15 homes are still in the
process of eliminating remaining cases. External audit results have
been gradually made public in the Spanish media.
Discussion
A person-centered, multicomponent intervention was designed
and implemented in 41 nursing homes to improve global care and to
reduce physical restraints. As expected, the study samplewas very old,
predominantly women, and almost two-thirds of the residents had
dementia (Table 1). These ﬁgures, which are consistent with previous
studies,2,6 were even increased in the second wave, pointing to a
nursing home future of predominantly women, mostly with demen-
tia, and very old. Because these people are highly vulnerable to per-
manent use of restraints, the aim of reducing or even eliminating
restraints in a safe and cost-effective way emerges as a challenging
and necessary step to improving physical status, psychological well-
being, and quality of life of institutionalized people with dementia
in most countries with developed or developing social services.
Interventions to reduce physical restraints differ widely in
results.16e21 In a comprehensive review of nonpharmacological ther-
apies (NPTs),22 we described a pattern bywhich themore components
a psychosocial intervention had, the more numbers of clinical areas
beneﬁted. Moreover, the NPT displayed a highly speciﬁc effect, with
tight correspondence between target areas and observed beneﬁts.
This pattern could also apply to psychosocial interventions to modify
organizational behavior. Possibly, the use of restraints in institutions
arises from interplay of multiple factors. For that reason, our inter-
vention was designed with several distinct components aimed at
delivering person-centered care in various dimensions: behavior,
perception, falls, nutrition, ethics, dementia knowledge, drugs, resi-
dents’ relatives, environment, and architectural design (Figure 1).
The intervention was successfully implemented in all the nursing
homes and important reduction in restraints was attained both in the
residents who remained in the nursing home during both study waves
(restraint reduction) and, even more, in the residents who were
admitted during the implementation of the restraint reduction and
prevention program (Table 2). In fact, a frequency of only 1.2%
restrained people was achieved for those residents who were
admitted in the nursing homes once the restraint-reduction program
had been initiated (1.8% in the residents with dementia).
The reduction of physical restraints was not accompanied by
increment of psychotropic medication prescription. Rather, reduction
in psychotropic mediations was also documented, particularly in pa-
tients with dementia (Table 3). Use of sedative drugs is sometimes
argued to cause falls, accidents, or other risks, and these prescriptions
frequently go together with use of physical restraints, thus creating a
type of “malignant” or “vicious circle” of increasing physical debilita-
tion, risk of falling, and use of restraint.23,24 In patients with dementia,
that circle is particularly fueled by the presence of BPSD and the use of
medications trying to treat those symptoms (Figure 2). Our program of
elimination of restraints was accompanied by an educational program
of psychotropic medication reduction and optimization. In case of pa-
tients with physical restraints, the reduction of sedative medication
was systematically considered to prevent falls. Although global
reduction in neuroleptic usewas not achieved, therewas a remarkablereduction in BZDprescription (Table 3),whichmayhave contributed to
fall prevention, particularly in the case of long half-life BZDs.25
Although restraints and psychotropic medications were reduced,
some increase in falls could not be avoided (Table 4). Similar results have
been reported elsewhere.10,17,26 In the present study, fall increase was
due to residents admitted in the new restraint-free environment but not
due to those residents untied. Hence, untying with the methodology
herein described appears to be safe. What makes the present study
unique is that, in addition to anacceptable sample size, our fall data refer
to an organization in which restraints were almost eliminated.
Extrapolating, falls in the ﬁrst year would have been 157 falls per
100 bed-years, rising to 193 falls in the second wave, both within
acceptable ranges.27 Besides that increase, any kind of fractures with
regard to total falls dropped from 1.7% to 1.5%, again below the 2.0% to
6.0% reported elsewhere.28 In spite of the lack of statistical signiﬁ-
cance, these falls deserve detailed future investigation.
Factors that could have contributed to more falls might have been
increased environmental clutter coming along with a rise in occu-
pancy from 80.9% to 92.3%, or slightly differing staff-to-resident ratios.
The second wave showed a higher proportion of frequent fallers (2.8%
vs 1.9%), which suggests that families and staff might have evolved
intomore tolerancewith falls of people that before the programwould
have been restrained. Permanently restrained lives are neither ethi-
cally nor legally an option.We agree with others29 that sitting, and not
restraints, should be considered a last resort. Life without restraints
implies movement and its intrinsic risks. For that reason, we believe
that it is mistaken to use fall and fracture rates of highly restrictive
homes as a standard by which to measure homes that lawfully use
restraints only on rare exceptions.
The yearly performed customer satisfaction enquiry of the chain
reported that the year of the ﬁrst wave, 799 (36.4%) of 2196 residents
(or families on their behalf) rated global service quality as excellent or
very good and 1414 (65.1%) of 2172 for the year of the second wave.
This prominent improvement might give a hint of the so-often
neglected subjective dimension of these programs.
The present study had some limitations. Recliner chairs used as
physical restraints were not tracked in our database. However, 26
homes that were audited by third party and certiﬁed as having zero
restraints included checking for recliner chairs as physical restraints.
Use of one-piece jumpsuit pajamas was also not accounted for. Our
R. Muñiz et al. / JAMDA 17 (2016) 633e639 639results regarding safety are based on the analysis of 2 months, and not
of 2 trimesters or years, accumulations that could potentially reduce
error. We controlled drugs prescribed, not dosage, which may have
varied along with restraint reduction.
In conclusion, our results demonstrated that physical restraints can
almost be eliminated together with a reduction of psychotropic
medication. However, a signiﬁcant increase in falls occurred. Future
research should address ways to avoid injurious falls in restraint-free
nursing homes, especially for people with severe dementia.
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